Non Animal Testing Database

Novel tau biomarkers for presymptomatic Alzheimer’s disease

November 2020
Barcelonaβeta Brain Research Center (BBRC), Barcelona, Spain(1)
University of Gothenburg, Gothenburg, Sweden(2)
The researchers have found three new forms of the tau protein that become abnormal in the very early stages of Alzheimer's disease before cognitive problems develop and can be thus used as diagnostic biomarkers. The scientists developed new tools to detect these subtle changes and confirmed their results in two studies with 381 and 503 human participants, respectively. The findings are also important for the testing of therapies against Alzheimer's disease.
Novel tau biomarkers phosphorylated at T181, T217 or T231 rise in the initial stages of the preclinical Alzheimer’s continuum when only subtle changes in Aβ pathology are detected
José Luis Molinuevo(1), Kaj Blennow(2)
Added on: 01-29-2021
Back to Top
English German

Warning: Internet Explorer

The IE from MS no longer understands current scripting languages, the latest main version (version 11) is from 2013 and has not been further developed since 2015.

Our recommendation: Use only the latest versions of modern browsers, for example Google Chrome, Mozilla Firefox or Microsofrt Edge, because only this guarantees you sufficient protection against infections and the correct display of websites!